Kalaris Therapeutics Inc. (KLRS)
NASDAQ: KLRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
KLRS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $60.94M
- EPS (TTM)
- -$1.95
- Dividend yield
- None
- 52-week range
- 2.51 – 11.88
- Day range
- 2.53 – 2.69
- Volume / Avg
- 74.12K / 254.23K
- Beta
- —
- Shares outstanding
- 23.80M
52-week range
KLRS stock today
Kalaris Therapeutics (KLRS) closed at $2.56 on Oct 7, down 3.76% (-$0.10), versus the S&P 500's 0.22% decline. Trading was light, with 74.12K shares changing hands, about 29% of the average daily volume. At this level, KLRS sits near the bottom of its 52-week range of $2.51 to $11.88: 78.5% below the high, set on Dec 18, 2025 and 2.0% above the low.
KLRS is down 69.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 66.8%. Kalaris Therapeutics has posted a net loss over the last twelve months (EPS of -$1.95), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Kalaris Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2020
Kalaris Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ELOXEloxx Pharmaceuticals Inc. | 14.88 | -1.65% | $60.06M | vs KLRS |
| INKTMiNK Therapeutics Inc. | 11.42 | -3.47% | $58.28M | vs KLRS |
| CRBUCaribou Biosciences Inc. | 0.6174 | -45.60% | $66.19M | vs KLRS |
| LONALeonaBio Inc. | 5.83 | +1.39% | $54.93M | vs KLRS |
| BKHABlack Hawk Acquisition Corporation Class A | 13.00 | +5.69% | $54.00M | vs KLRS |
| CSBRChampions Oncology Inc. | 4.88 | -2.59% | $67.92M | vs KLRS |
| IMAImageneBio Inc. | 4.61 | -1.91% | $52.43M | vs KLRS |
| INMBINmune Bio Inc. | 1.86 | -0.53% | $51.62M | vs KLRS |
Indexes, lists and sector
Kalaris Therapeutics stock FAQ
What is Kalaris Therapeutics's stock price today?
KLRS last traded at $2.56 as of Oct 7, 4:00 PM EDT, down 3.76% on the day. Prices are delayed at least 15 minutes.
Does Kalaris Therapeutics pay a dividend?
No. Kalaris Therapeutics does not currently pay a regular cash dividend.
Has KLRS ever split its stock?
Yes. The most recent KLRS stock split was a 1-for-23 split on Jan 16, 2025.
What is the KLRS 52-week high?
The 52-week high for KLRS is $11.88 and the 52-week low is $2.51. The stock is currently 78.5% below its high.